DB15470InvestigationalProtein Based Therapies
Minretumomab: Overview.
- Also known as
- CC49 monoclonal antibody · Monoclonal antibody CC49
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Minretumomab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account